-
Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions.
J Immunol. 2006 Jan 15;176(2):1107-14
PMID: 16393999
-
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.
J Immunol Methods. 2006 Jan 20;308(1-2):53-67
PMID: 16343526
-
Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity.
FEMS Immunol Med Microbiol. 2006 Nov;48(2):267-73
PMID: 16978244
-
A conformational epitope expressed upon association of CD3-epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies.
J Immunol. 1991 Nov 1;147(9):3047-52
PMID: 1717585
-
The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.
Microbes Infect. 2003 Sep;5(11):1029-39
PMID: 12941395
-
NK cells in HIV infection: paradigm for protection or targets for ambush.
Nat Rev Immunol. 2005 Nov;5(11):835-43
PMID: 16239902
-
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.
J Infect Dis. 2003 Apr 1;187(7):1038-45
PMID: 12660917
-
Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia.
J Infect Dis. 2004 Apr 1;189(7):1193-8
PMID: 15031787
-
Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1.
Curr HIV Res. 2004 Jul;2(3):255-70
PMID: 15279589
-
Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection.
J Clin Immunol. 2001 May;21(3):227-33
PMID: 11403230
-
Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users.
J Immunol. 2003 Dec 1;171(11):5663-7
PMID: 14634071
-
HIV vaccine design and the neutralizing antibody problem.
Nat Immunol. 2004 Mar;5(3):233-6
PMID: 14985706
-
HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity.
Curr HIV Res. 2003 Jul;1(3):295-307
PMID: 15046254
-
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
Nat Genet. 2002 Aug;31(4):429-34
PMID: 12134147
-
Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice.
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7545-9
PMID: 7638228
-
The rational design of an AIDS vaccine.
Cell. 2006 Feb 24;124(4):677-81
PMID: 16497577
-
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
J Exp Med. 2006 Oct 2;203(10):2339-50
PMID: 17000867
-
Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.
J Immunol. 2005 Feb 15;174(4):2185-9
PMID: 15699150
-
Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation.
J Virol. 2008 Jan;82(2):893-902
PMID: 17959659
-
Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.
J Immunol. 2007 Oct 1;179(7):4571-9
PMID: 17878354
-
A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection.
J Virol. 1997 Feb;71(2):925-33
PMID: 8995609
-
Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.
Blood. 1988 Mar;71(3):603-12
PMID: 3278747
-
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91
PMID: 15699323
-
Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells.
Clin Vaccine Immunol. 2006 Jul;13(7):768-78
PMID: 16829614
-
Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1.
J Virol. 2005 Jun;79(12):7728-37
PMID: 15919925
-
Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS.
AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1197-205
PMID: 12487826
-
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
Nature. 1991 Dec 12;354(6353):453-9
PMID: 1721107
-
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
Vaccine. 2005 Mar 31;23(19):2522-9
PMID: 15752839
-
Antibody neutralization and escape by HIV-1.
Nature. 2003 Mar 20;422(6929):307-12
PMID: 12646921
-
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15011-6
PMID: 14645713
-
Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface.
J Immunol. 2004 Feb 15;172(4):2401-6
PMID: 14764710
-
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads.
J Infect Dis. 2004 Dec 1;190(11):1970-8
PMID: 15529262
-
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.
J Immunol Methods. 2001 Sep 1;255(1-2):27-40
PMID: 11470284